The short answer most patients don't expect

For many people, the first instinct when a knee starts aching is to stop walking — to rest it, protect it, avoid 'wearing it out further.' That instinct is understandable, but the evidence points firmly in the opposite direction: for the majority of people with damaged knee cartilage or knee osteoarthritis (OA), walking is beneficial, and sustained inactivity is the greater structural threat.

This is not a cautious clinical opinion. The OARSI 2019 guidelines — the field's most-cited reference for non-surgical knee OA management, with over 4,300 citations — classify structured land-based exercise including walking as a universal core treatment, recommended regardless of OA severity or other health conditions. That classification was reaffirmed in the 2024 OARSI Year in Review.

Large cohort data back this up directly. The MOST trial, which followed 1,462 patients over two years using MRI to measure cartilage change, found that higher levels of walking and physical activity were associated with a 5% reduction in odds of cartilage loss per half-decile increase in activity. Counterintuitively, it was time spent lying down — not walking — that predicted greater cartilage deterioration.

These findings hold most clearly across mild-to-moderate OA. Important nuances apply in severe disease, and the question of how you walk matters as much as whether you walk — both are addressed in the sections that follow.

Why cartilage actually needs movement to stay healthy

The cartilage lining the knee joint has no direct blood supply. Unlike muscle or bone, it is avascular — it cannot draw oxygen and nutrients from circulating blood and relies almost entirely on synovial fluid, the lubricating liquid that fills the joint space.

Movement is what drives that supply. Each walking stride compresses the cartilage, pressing fluid and metabolic waste products out of the matrix. When the load releases between steps, fresh synovial fluid is drawn back in, delivering oxygen and nutrients to the cartilage cells. Think of a wet sponge being squeezed and released — the cycling of load is what keeps the exchange going.

When movement stops, the exchange stalls. Cartilage cells begin to starve, waste products accumulate, and the matrix breaks down faster than it otherwise would. This is why extended rest, though intuitively protective, can work against the joint — a mechanism that makes sense of the MOST trial finding described in the previous section, where lying down predicted structural deterioration while walking did not.

This also reframes the 'wear and tear' mental model that many patients bring to a first consultation. Cartilage is not a passive material ground down by use; it is a living tissue that depends on cyclic mechanical loading to stay nourished and viable. The problem, in most cases of knee OA, is too little movement — not too much.

What the clinical evidence actually shows

The most direct test of the 'walking wears out the joint' assumption comes from the MOST cohort — 1,462 adults (mean age 61, 59% women) followed for two years, with cartilage change measured by MRI rather than symptom questionnaire. Each half-decile increase in walking, standing, or maximum-level physical activity was associated with a 5% reduction in the odds of cartilage loss. A sensitivity analysis that replaced walking time with raw step count confirmed the same direction of effect — an important methodological detail, since it makes it unlikely the result was an artefact of how activity was categorised rather than a genuine dose relationship.

Two aspects of this finding deserve close reading. First, the primary endpoint was structural: cartilage volume on MRI, not pain scores or patient-reported function. The trial tells us what walking does to the tissue itself. It does not tell us how much a walking programme alters what a patient feels day to day — those two things are related but not equivalent, and the pain picture is addressed in the section that follows.

Second, this is a structural protective signal measured across a population that included people with established knee OA — not a sample of healthy joints. The protection was observed in tissue that was already compromised.

On the guideline side, the 2024 OARSI Year in Review (Lawford et al.) continued affirming exercise as foundational to knee OA management, extending the evidence base consolidated by the 2019 Bannuru guidelines without reversing any core recommendation. Where the literature has not yet established equivalent proof is in pain outcomes specifically — the structural and symptomatic evidence bases remain somewhat decoupled.

How much walking, and does severity change the answer?

Practical dose guidance emerges from two trials by Wallis and colleagues that tested supervised walking specifically in people with severe knee OA. The 2015 study established 70 minutes per week of moderate-intensity walking as the maximum tolerated and safe dose at this disease stage — a useful anchor, since many patients and clinicians are unsure how far to push activity when structural damage is significant.

The 2017 follow-up applied that dose over 12 weeks. Cardiovascular gains were observed, but knee pain scores did not improve significantly compared to control. That null pain finding is worth taking at face value: walking at this dose, in severe disease, appears insufficient as a standalone pain treatment. It does not contradict the structural evidence reviewed earlier — cartilage volume and pain scores measure different things, and a walking programme can protect tissue without producing the symptom relief a patient is hoping for.

At Kellgren–Lawrence grade 4 (end-stage OA), the structural protection signal from walking also thins. The evidence base that supports walking as cartilage-preserving is strongest in mild-to-moderate disease; at the severe end, the primary documented benefit shifts toward cardiovascular and general conditioning rather than joint-level protection.

The practical implication is clear: walking belongs in a conservative programme, not as the whole of one. For advanced OA in particular, evidence consistently supports combining walking with progressive quadriceps and gluteal strengthening, and potentially with adjunct treatments. A walking routine is the accessible, low-equipment component — but it works best when it is one part of a structured approach rather than the plan in full.

One important caveat on interpreting the dose literature: most walking trials are underpowered to detect pain differences as a primary endpoint. An absence of statistically significant pain reduction is not proof that no effect exists — it reflects the limits of the studies available.

How you walk matters as much as whether you walk

Walking frequency and duration are not the only variables that matter. For some patients — particularly those with marked varus (bow-legged) alignment — the mechanics of how each step loads the joint may be as relevant as how many steps they take.

Biomechanical research has identified elevated tibiofemoral contact forces, and specifically high knee adduction moment impulse during gait, as significant predictors of radiographic OA progression over three years. In practical terms, load is concentrated toward the inner (medial) compartment rather than shared evenly across the joint surface. In those with varus alignment, this bias is structurally amplified. The implication is not that walking is harmful; it is that individual anatomy can shift the load-distribution assumption underpinning a generic walking prescription.

A 2025 Stanford study introduced a clinically relevant development here: personalised gait retraining — modifying the specific way an individual walks, rather than simply prescribing more of it — slowed cartilage degradation and produced pain relief comparable to medication in knee OA patients. The approach targets adduction moment directly, adjusting parameters such as foot progression angle, step width, or trunk lean to redistribute joint load.

That evidence remains early-stage and has not yet been incorporated into major guidelines such as OARSI; gait retraining sits in the category of promising adjuncts rather than standard prescription. For patients with atypical presentations, rapid structural progression, or significant biomechanical asymmetry, it nonetheless illustrates why specialist assessment can extend beyond diagnosis to the specific mechanics of how a patient moves.

Walking inside a complete conservative programme

Walking sits inside a wider conservative hierarchy, not at its top. The TeMPO consensus protocol — developed for knee OA with degenerative meniscal tears — integrates progressive strengthening, manual therapy, and neuromuscular functional training alongside a home exercise programme in which walking serves as the accessible, self-directed mobility component. The architecture matters: quadriceps and hip-abductor conditioning directly reduces compressive joint load, and manual therapy addresses range-of-motion deficits that walking alone cannot correct. Walking anchors adherence precisely because it requires no equipment, no clinic attendance, and no supervision — but it works best when embedded in that fuller structure, not substituted for it.

Patients who plateau on a self-managed walking programme — or whose pain escalates despite consistent effort — should be assessed by a specialist rather than simply advised to walk more. That plateau is a clinical signal: it may indicate that injection support, gait retraining, or a cartilage-preservation assessment would add value beyond what a walking programme alone can provide. For patients in London, the London Cartilage Clinic on Harley Street offers that structured assessment point; appointments can be arranged via londoncartilage.com.

The evidence reviewed here is unusually consistent in its direction: walking — done thoughtfully, at appropriate dose, within a structured programme — supports cartilage nutrition, slows structural deterioration, and remains one of the most durable tools in conservative knee care. For most patients, the instinct to stop moving is the one thing most worth reconsidering.

1. [1] High tibiofemoral contact and muscle forces during gait are associated with radiographic knee OA progression over 3 years. (2023). https://doi.org/10.1016/j.knee.2023.01.012 https://doi.org/10.1016/j.knee.2023.01.012
2. [2] A consensus-based process identifying physical therapy and exercise treatments for patients with degenerative meniscal tears and knee OA: the TeMPO physical therapy interventions and home exercise program. (2019). https://doi.org/10.1186/s12891-019-2872-x https://doi.org/10.1186/s12891-019-2872-x